Top medical journal Lancet has begun to probe a controversial study on the use of antimalarial drug hydroxychloroquin in treating COVID-19 patients after receiving complaints from several quarters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback